Key Takeaways CLB posted Q4 adjusted EPS of 21 cents on $138.3M revenues, topping consensus estimates.Production Enhancement revenues rose 8.3% to $46M, swinging to a $3M operating profit on tech adoption.CLB guided Q1 2026 revenues of $124M-$130M and EPS of 11-15 cents amid volatile markets.Core Laboratories Inc. (CLB) reported fourth-quarter 2025 adjusted earnings of 21 cents per share, which beat the Zacks Consensus Estimate of 20 cents. This can be attributed to the outperformance of the Production Enha ...